XML 23 R11.htm IDEA: XBRL DOCUMENT v3.24.2
INTANGIBLE ASSETS
3 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLE ASSETS

NOTE 5 - INTANGIBLE ASSETS

 

The Company has the following intangible assets:

 

Intangible assets consisted of the following:

SCHEDULE OF INTANGIBLE ASSETS

 

                          
   Patents   Trademarks  

Intellectual

Property

  

Capitalized

Acquisition

Costs

   Total 
Cost:                         
At December 31, 2023  $220,926   $36,558   $3,109,540   $45,745   $3,412,769 
Additions   15,139    427    -    -    15,566 
Effects of currency translation   (1,718)   (285)   (24,180)   -    (26,183)
At March 31, 2024  $234,347   $36,700   $3,085,360   $45,745   $3,402,152 
                          
Less accumulated amortization:                         
At December 31, 2023  $8,541   $-   $1,940,736   $6,864   $1,956,141 
Amortization expense   1,630    -    49,287    572    51,489 
Effects of currency translation   (70)   -    (15,089)   -    (15,159)
At March 31, 2024  $10,101   $-   $1,974,934   $7,436    1,992,471 
                          
Net book value                         
At March 31, 2024  $224,246   $36,700   $1,110,426   $38,309   $1,409,681 
At December 31, 2023  $212,385   $36,558   $1,168,804   $38,881   $1,456,628 

 

  Patents

 

A Patent on the Internet-Search Mechanism (“IBSM”) has been granted in the United States, South Africa, New Zealand, Canada, and Australia. The patent is pending in the European Union, and the United Kingdom.

 

Patents on Contextual Enveloping of Dynamic Hypertext Links and Real-Time Data Processing are pending in the United States

 

Patents are reported at cost, less accumulated amortization, and accumulated impairment loss. Costs include expenditure that is directly attributable to the acquisition of the asset. Once a patent provides economic benefit to the Company, amortization is provided on a straight-line basis on all patents over their expected useful lives of 20 years.

 

 

  Intellectual Property

 

Intellectual Property capitalizes the Company’s qualifying internal research and developments costs. Intellectual property is amortized over its useful life of 7 years and reported at cost less accumulated amortization and accumulated impairment loss.

 

  Trademarks

 

The Company has the following trademarks.

 

Mark   Category   Proprietor   Country   Class(es)   Status   Reg. Date.   File No.
CITIZENS JOURNALIST   Words   Bubblr Limited   European Union   9 38   REGISTERED   16-Nov-2019   206382.EM.01
CITIZENS JOURNALIST   Word   Bubblr Limited   United Kingdom   9 38   REGISTERED   05-Jul-2019   206382.GB.01
CITIZENS JOURNALIST   Words   Bubblr Limited   United Kingdom   9 38   REGISTERED   16-Nov-2019   206382.GB.02
CITIZENS JOURNALIST   Word   Bubblr Limited   United States   9 38 41 42   REGD-DEC USE   08-Feb-2022   206382.US.01
  Words and Color Device   Bubblr Limited   European Union   9 38   REGISTERED   16-Nov-2019   206383.EM.01
  Series of Logos   Bubblr Limited   United Kingdom   9 38   REGISTERED   05-Jul-2019   206383.GB.01
  Words and Color Device   Bubblr Limited   United Kingdom   9 38   REGISTERED   16-Nov-2019   206383.GB.02
  Words and Device   Bubblr Limited   United States   9 38 41 42   ACCEPTED       206383.US.01
BAU NOT OK/BAU Not OK   Series of Marks   Bubblr Limited   United Kingdom   9 38   REGISTERED   11-Oct-2019   208674.GB.01
NEWZMINE/NewzMine   Series of Marks   Bubblr Limited   United Kingdom   9 38 42   REGISTERED   25-Dec-2020   227753.GB.01

 

The Company capitalizes trademark costs where the likelihood of acceptance is expected. Each trademark has been determined to have an infinite useful life and is assessed each reporting period for impairment. If there has been a reduction in the value of the trademark or if the trademark is not successfully registered, the assets will be impaired and charged to expense in the period of impairment.

 

Amortization expense was $51,489 and $56,521 for the three months ended March 31, 2024 and 2023, respectively.